Rosetta Genomics Ltd. (ROSG) gapped open higher Thursday morning and has continued to rise in early trade. The stock is now up 4.20 at $15.44.
Rosetta Genomics has been climbing for over a week on above average volume and has set a 7-month high. The stock has been rising since it announced that it obtained Medicare coverage for its miRview mets² assay on May 16th.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.